Skip to content
Thursday, November 12, 2026
BritSlotLink

Individuals Coming Off Slimming Injections Put On Weight Far More Rapidly Than People Using Diet and Exercise

Image of medical syringe and weighing machine
Weight management often requires long-term strategies.

Fresh analysis reveals that people who discontinue new GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle regimens.

Findings released in a prominent medical journal points out that while overweight people can lose substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"Users buying such treatments must be cognizant of the potential of quick weight regain when the medication ends," warns expert Dr. Susan Jebb.

That rate of recovery means a return to original weight within about 18 months.

Analyzing Treatments

The research, which examined 37 of studies involving thousands of patients, compared the results of these new drugs with conventional dieting.

Scientists point out that people who shed pounds through dieting generally have a more gradual creep back—around 0.1 kg a month—once they finish.

Understanding the Quick Regain

Doctors suggest the way of the injections explains the heightened weight return.

These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this GLP-1 'fix' means hunger is uncontrolled, making binge eating much more probable."

A Chronic Issue?

The NHS recommend the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.

A number of clinicians argue that, due to the likelihood of weight regain, the therapy might need to be long-term.

This view is echoed by pharmaceutical companies, who state that the results "highlight the persistent nature of obesity," akin to managing diseases like diabetes.

User Accounts

Individuals who have discontinued the medication describe a intense resurgence of cravings.

"I experienced something that goes on and you're instantly extremely hungry," described an individual.

The struggle is exacerbated if patients have not established permanent lifestyle or habit changes during therapy.

Significant Adoption

Recent estimates show that millions of people in the UK have used these injections in the last 12 months, with demand being substantial.

  • Use is higher among women than men.
  • The middle-aged demographic shows the greatest usage rates.
  • Many access the drugs through private healthcare rather than the NHS.

Finally, experts caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent solution and long-term success likely depends on combined behavioural changes.

AM
About the author

Alec Mejia

Eleanor is a seasoned online slot reviewer with over a decade of experience in the UK gambling industry.

BritSlotLink

Type to search articles.